The Cancer Genome as a Novel Target for Malignant Osteosarcoma Immunotherapy
Abstract: Osteosarcoma (OS) is a rare but devastating form of bone cancer that often affects pediatric populations. Patient survival is highly dependent on the stage of OS diagnosis. If identified early, when cancer remains localize... Read More